$26.10 Million in Sales Expected for Aspen Aerogels Inc (NYSE:ASPN) This Quarter
Brokerages expect Aspen Aerogels Inc (NYSE:ASPN) to report sales of $26.10 million for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Aspen Aerogels' earnings. The highest sales estimate is $26.60 million and the lowest is $25.70 million. Aspen Aerogels reported sales of $35.43 million in the same quarter last year, which would suggest a negative year over year growth rate of 26.3%. The business is expected to report its next quarterly earnings report after the market closes on Thursday, October 29th.
On average, analysts expect that Aspen Aerogels will report full-year sales of $106.87 million for the current fiscal year, with estimates ranging from $105.10 million to $108.10 million. For the next year, analysts anticipate that the company will report sales of $132.81 million, with estimates ranging from $119.90 million to $140.00 million. Zacks Investment Research's sales calculations are an average based on a survey of analysts that follow Aspen Aerogels.
Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Thursday, July 30th. The construction company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.01). The business had revenue of $24.64 million during the quarter, compared to analyst estimates of $22.60 million. Aspen Aerogels had a negative net margin of 8.97% and a negative return on equity of 19.00%.
Several research firms have recently issued reports on ASPN. Canaccord Genuity re....